Tokyo Tape
Sign in
← Medipal Holdings

Quarterly report · Q1

7459.TEDINET S100OYEC
Period2022-04-01 → 2022-06-30
Filed2022-08-10
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 34
MetricValuePeriodScopeSource row
Revenue¥838.3bn2022-04-01 → 2022-06-30Cons.Net sales
Revenue¥3.29T2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥824.9bn2021-04-01 → 2021-06-30Cons.Net sales
Operating income¥13.5bn2022-04-01 → 2022-06-30Cons.Operating income
Operating income¥13.3bn2021-04-01 → 2021-06-30Cons.Operating income
Ordinary income¥17.6bn2022-04-01 → 2022-06-30Cons.Ordinary income
Ordinary income¥62.0bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥17.4bn2021-04-01 → 2021-06-30Cons.Ordinary income
Profit before tax¥17.2bn2022-04-01 → 2022-06-30Cons.Income before income taxes
Profit before tax¥17.5bn2021-04-01 → 2021-06-30Cons.Income before income taxes
Net income (owners)¥8.3bn2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥29.4bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥9.4bn2021-04-01 → 2021-06-30Cons.Profit loss attributable to owners of parent
Net income¥10.8bn2022-04-01 → 2022-06-30Cons.Profit loss
Net income¥12.2bn2021-04-01 → 2021-06-30Cons.Profit loss
Total assets¥1.72Tat 2022-06-30Cons.Assets
Total assets¥1.71Tat 2022-03-31Cons.Assets
Total assets¥1.70Tat 2021-06-30Cons.Total assets (5-year summary)
Total liabilities¥1.06Tat 2022-06-30Cons.Liabilities
Total liabilities¥1.06Tat 2022-03-31Cons.Liabilities
Net assets / equity¥659.0bnat 2022-06-30Cons.Net assets
Net assets / equity¥649.1bnat 2022-03-31Cons.Net assets
Net assets / equity¥645.5bnat 2021-06-30Cons.Net assets (5-year summary)
Cash and deposits¥218.8bnat 2022-06-30Cons.Cash and deposits
Cash and deposits¥243.2bnat 2022-03-31Cons.Cash and deposits
EPS (basic)¥39.392022-04-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥140.142021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥44.992021-04-01 → 2021-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥36.942022-04-01 → 2022-06-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥131.412021-04-01 → 2022-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥42.222021-04-01 → 2021-06-30Cons.Diluted earnings per share (5-year summary)
Equity ratio31.4%at 2022-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio31.0%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio31.1%at 2021-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 38
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-06-30−¥913m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-06-30−¥913m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-06-30¥98m
jpcrp040300-q1r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segmentrevenue2022-04-01 → 2022-06-30¥18.5bn
jpcrp040300-q1r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segmentrevenue external2022-04-01 → 2022-06-30¥18.5bn
jpcrp040300-q1r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥1m
jpcrp040300-q1r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segmentsegment profit2022-04-01 → 2022-06-30¥692m
jpcrp040300-q1r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segmentrevenue2022-04-01 → 2022-06-30¥276.2bn
jpcrp040300-q1r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segmentrevenue external2022-04-01 → 2022-06-30¥276.2bn
jpcrp040300-q1r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥94m
jpcrp040300-q1r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segmentsegment profit2022-04-01 → 2022-06-30¥6.5bn
jpcrp040300-q1r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentrevenue2022-04-01 → 2022-06-30¥544.4bn
jpcrp040300-q1r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentrevenue external2022-04-01 → 2022-06-30¥543.6bn
jpcrp040300-q1r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥817m
jpcrp040300-q1r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentsegment profit2022-04-01 → 2022-06-30¥6.2bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-06-30¥839.2bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-06-30¥838.3bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-06-30¥913m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-06-30¥13.4bn
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-06-30−¥937m
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-06-30−¥937m
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-06-30¥169m
jpcrp040300-q1r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segmentrevenue2021-04-01 → 2021-06-30¥18.1bn
jpcrp040300-q1r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segmentrevenue external2021-04-01 → 2021-06-30¥18.1bn
jpcrp040300-q1r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥0
jpcrp040300-q1r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segmentsegment profit2021-04-01 → 2021-06-30¥734m
jpcrp040300-q1r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segmentrevenue2021-04-01 → 2021-06-30¥269.7bn
jpcrp040300-q1r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segmentrevenue external2021-04-01 → 2021-06-30¥269.6bn
jpcrp040300-q1r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥90m
jpcrp040300-q1r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segmentsegment profit2021-04-01 → 2021-06-30¥7.0bn
jpcrp040300-q1r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentrevenue2021-04-01 → 2021-06-30¥538.0bn
jpcrp040300-q1r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentrevenue external2021-04-01 → 2021-06-30¥537.1bn
jpcrp040300-q1r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥846m
jpcrp040300-q1r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentsegment profit2021-04-01 → 2021-06-30¥5.4bn
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-06-30¥825.8bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-06-30¥824.9bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2021-06-30¥937m
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-06-30¥13.1bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 379
ItemContextValueUnit
Gross profitCurrentYTDDuration56026000000JPY
Salaries and allowances sgaPrior1YTDDuration16221000000JPY
Salaries and allowances sgaCurrentYTDDuration16137000000JPY
Welfare expenses sgaPrior1YTDDuration3055000000JPY
Welfare expenses sgaCurrentYTDDuration2977000000JPY
Provision for bonuses sgaPrior1YTDDuration2933000000JPY
Provision for bonuses sgaCurrentYTDDuration2406000000JPY
Retirement benefit expenses sgaPrior1YTDDuration834000000JPY
Retirement benefit expenses sgaCurrentYTDDuration757000000JPY
Distribution expenses sgaPrior1YTDDuration4761000000JPY
Distribution expenses sgaCurrentYTDDuration4745000000JPY
Rents sgaPrior1YTDDuration1093000000JPY
Rents sgaCurrentYTDDuration1025000000JPY
Depreciation sgaPrior1YTDDuration3086000000JPY
Depreciation sgaCurrentYTDDuration3030000000JPY
Other sgaPrior1YTDDuration9785000000JPY
Other sgaCurrentYTDDuration11429000000JPY
Selling general and administrative expensesPrior1YTDDuration41773000000JPY
Selling general and administrative expensesCurrentYTDDuration42509000000JPY
Operating incomePrior1YTDDuration13282000000JPY
Operating incomeCurrentYTDDuration13516000000JPY
Interest income noiPrior1YTDDuration42000000JPY
Interest income noiCurrentYTDDuration41000000JPY
Dividends income noiPrior1YTDDuration831000000JPY
Dividends income noiCurrentYTDDuration837000000JPY
Research fee income noiPrior1YTDDuration2018000000JPY
Research fee income noiCurrentYTDDuration2077000000JPY
Real estate rent noiPrior1YTDDuration305000000JPY
Real estate rent noiCurrentYTDDuration495000000JPY
Equity in earnings of affiliates noiPrior1YTDDuration790000000JPY
Equity in earnings of affiliates noiCurrentYTDDuration600000000JPY
Other noiPrior1YTDDuration265000000JPY
Other noiCurrentYTDDuration276000000JPY
Non operating incomePrior1YTDDuration4254000000JPY
Non operating incomeCurrentYTDDuration4329000000JPY
Interest expenses noePrior1YTDDuration4000000JPY
Interest expenses noeCurrentYTDDuration3000000JPY
Rent expenses on real estates noePrior1YTDDuration142000000JPY
Rent expenses on real estates noeCurrentYTDDuration234000000JPY
Other noePrior1YTDDuration26000000JPY
Other noeCurrentYTDDuration21000000JPY
Non operating expensesPrior1YTDDuration174000000JPY
Non operating expensesCurrentYTDDuration259000000JPY
Ordinary incomePrior1YTDDuration17362000000JPY
Ordinary incomeCurrentYTDDuration17586000000JPY
Gain on sales of noncurrent assets eiPrior1YTDDuration14000000JPY
Gain on sales of noncurrent assets eiCurrentYTDDuration－JPY
Gain on sales of investment securities eiPrior1YTDDuration6000000JPY
Gain on sales of investment securities eiCurrentYTDDuration3442000000JPY
Gain on reversal of provision for loss on disaster eiPrior1YTDDuration94000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass rounding
balance sheet identityconsolidated 2022-06-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-06-30pass